Depomed appoints new CMO
This article was originally published in Scrip
Executive Summary
Newark, California-based Depomed, a specialty pharmaceutical company that commercializes products for pain and neurology related disorders, has named Dr Srinivas G Rao chief medical officer and senior vice-president. Dr Rao, the founder and CEO of Kyalin Biosciences, a privately held biotechnology company acquired by Retrophin in 2013, was most recently executive vice-president and head of neuroscience at Retrophin.
You may also be interested in...
Finding Value Left On The Shelf: Karuna Case Study
PureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.
Podcast: NodThera On The Role Of The Brain In Driving Chronic Disease
Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, talks to In Vivo about the company’s pipeline and recent data publication in the field of obesity.
Deals Of The Year 2023 Winners Revealed
For In Vivo's 16th annual Deals of the Year contest, we selected 12 nominees in three categories – Top Alliance, Top Financing and Top M&A. The polls are closed, and it is time to reveal the winners.